The Beauty Health Company
The Beauty Health Company（SKIN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
skin · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Hold
14 位分析师
共识
评级分布
12 个月目标价
High
$2.00
Consensus
$1.53
+150.8% upside
Low
$1.00
Median: $1.6 · Last Close: $0.61
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$1.53
150.8% upside
High Target
$2
227.9%
Low Target
$1
63.9%
Current Price
$0.61
as of today
Based on analyst price targets, the SKIN stock price prediction for the next 12 months ranges from $1 to $2. The consensus SKIN price forecast of $1.53 implies 150.8% upside from the current price of $0.61.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.58 | ↓ 4.82% |
1-day model range: $0.56–$0.61. Peak: $0.61 (-4.82%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · SKIN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-20 | Roth Capital | Maintains | Buy→Buy |
| 2026-05-01 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-03-16 | TD Cowen | Maintains | Hold→Hold |
| 2026-03-13 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-01-21 | TD Cowen | Maintains | Hold→Hold |
| 2025-09-22 | TD Cowen | Maintains | Hold→Hold |
| 2025-08-01 | Stifel | Maintains | Hold→Hold |
| 2025-05-05 | Canaccord Genuity | Maintains | Hold→Hold |
| 2025-03-13 | Canaccord Genuity | Maintains | Hold→Hold |
| 2024-11-13 | Canaccord Genuity | Maintains | Hold→Hold |
Wall Street analysts have recently issued updated ratings on The Beauty Health Company (SKIN) stock. Of the recent 74 rating actions, 1 were upgrades and 10 were downgrades. 14 analysts currently cover SKIN.
分析师推荐趋势
SKIN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$328M
↑ 13.3% YoY
Revenue Next Year
$297M
↓ 9.5% YoY
EPS This Year
$-0.28
EPS Next Year
$-0.07
↓ 74.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast SKIN EPS of $-0.28 for the current fiscal year, based on estimates from 3 analysts. The SKIN revenue forecast is $328M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SKIN 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SKIN 的共识目标价为 $1.53（+150.8% 上行空间），分析师共识为 Hold。
SKIN 的短期预测（明日）为 $0.58（-4.82%）。 SKIN 对 2030 年的预测区间为 $0–$0。
The Beauty Health Company 在 NASDAQ 上市，代码 SKIN。SKIN 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 29% 对应 Hold 共识。
常见问题
SKIN 预测 · 8 个问题根据 14 位华尔街分析师，SKIN 的 12 个月平均目标价为 $1.53，最高 $2.00、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $0.61，隐含约 +150.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.